New Chinese patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the The Chinese patent office SIPO. The patent, entitled “Surgical kit for cartilage repair comprising implant and a set of tools”, has a focus on Episurf Medical’s individualised Episealer® Femoral Twin joint implant and its design process. "This patent forms a part of our global IP protection for the Episealer® Twin technology, which is an appreciated solution for elongated cartilage lesions in joints”, comments Katarina Flodström, COO, Episurf Medical. For more information, please contact: Pål Ryfors,